Dermatitis, Atopic: all 1,443 studies
Page 11 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)CompletedNCT03936335
- A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic DermatitisCompletedNCT03920852Phase 1
- Single Dose and Multiple Dose Study to Assess Safety and Tolerability of LOU064CompletedNCT03918980Phase 1
- Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic DermatitisStatus unknownNCT03907228Not applicable
- Scratch Behavior Under Standard of CareCompletedNCT03898427
- Sweat and Gas Sensor for Healthy Skin and Atopic DermatitisCompletedNCT03874039
- Monitoring Of Scratch Via Accelerometry In ChildrenCompletedNCT03873220
- Short-term Topical Application to Prevent Atopic DermatitisCompletedNCT03871998Not applicable
- Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic DermatitisCompletedNCT03868098Phase 4
- Probiotic Lactobacillus Rhamnosus GG for Pediatric Atopic DermatitisCompletedNCT03863418Not applicable
- Study in Subjects With Moderate Atopic DermatitisStatus unknownNCT03859986Phase 2
- Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY)CompletedNCT03849716
- Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic DermatitisTerminatedNCT03846466Phase 1
- Tencel vs. Standard Cotton Therapeutic Garments as an Adjunct Treatment for Moderate to Severe Atopic Dermatitis in ChildrenWithdrawnNCT03843437Not applicable
- Clinical, Psychological and Genetic Characteristics in Dermatological PatientsCompletedNCT03831646
- Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and ChildrenCompletedNCT03826901Phase 1
- Study to Evaluate the Use of a Probiotic in SCORAD Reduction in Young Patients With Atopic DermatitisStatus unknownNCT03822624Not applicable
- Hydration Sensor for Atopic DermatitisCompletedNCT03813472
- Moisturizer to Prevent Atopic DermatitisWithdrawnNCT03808532Phase 2
- Bone Health in Patients With Atopic DermatitisCompletedNCT03800004
- Study to Evaluate ASN008 Topical Gel (TG)CompletedNCT03798561Phase 1
- The Role of Bathing Additives in the Treatment of Pediatric Atopic DermatitisTerminatedNCT03775590Not applicable
- Wearable Skin Sensors to Assess Nocturnal Scratch BehaviorCompletedNCT03770858
- Assessment of the Impact of Whole Body Cryostimulation on Skin Physiological IndicatorsCompletedNCT03761199Not applicable
- A Study of KY1005 in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03754309Phase 2
- A Study of LY3454738 in Healthy Participants and Participants With Atopic DermatitisCompletedNCT03750643Phase 1
- Seal, Stopping Eczema and Allergy StudyActive, not recruitingNCT03742414Phase 2
- Eczema Reminder and Accountability ProgramCompletedNCT03735459Not applicable
- A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisCompletedNCT03733353Phase 1
- Improving Therapeutic Patient Education for Atopic Dermatitis: Evaluation of a Parent HandbookCompletedNCT03722706Not applicable
- Investigation of Flare and Remission in Subjects With Atopic DermatitisWithdrawnNCT03710044Phase 4
- A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic DermatitisTerminatedNCT03689829Phase 1
- Treatment of Nighttime Pruritus in Atopic DermatitisWithdrawnNCT03688464Early Phase 1
- Observational Evaluation of Atopic Dermatitis in Pediatric PatientsActive, not recruitingNCT03687359
- Comparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of AgeTerminatedNCT03684343Not applicable
- Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic DermatitisCompletedNCT03676933Phase 2
- Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic DermatitisCompletedNCT03676036Phase 2
- Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)CompletedNCT03672383Not applicable
- Educational Eczema Video InterventionWithdrawnNCT03664271Not applicable
- Effect of Different Skin Creams on TEWLCompletedNCT03663673Phase 1
- A Longitudinal Observational Study of Patients Undergoing Therapy for IMISCActive, not recruitingNCT03661866
- A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCompletedNCT03661138Phase 3
- A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic DermatitisCompletedNCT03646604Phase 1
- Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.CompletedNCT03634345Phase 1
- Evaluation and Comparison of 2 Cosmetic Investigational Products in Adults With Atopic DermatitisCompletedNCT03632174Not applicable
- A Trial of Antroquinonol in Patients With Atopic DermatitisCompletedNCT03622463Phase 2
- Bleach vs. Bubbles: Assessing the Impact of the Bathroom Environment on EczemaCompletedNCT03619161Not applicable
- Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic DermatitisCompletedNCT03614221Phase 2
- Effects of an Anti-TRPM8 in the Atopic Dermatitis PruritusCompletedNCT03610386Not applicable
- Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis PatientsCompletedNCT03571620Phase 2
- Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic DermatitisCompletedNCT03568136Phase 2
- A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic DermatitisTerminatedNCT03568071Phase 2
- Clinical vs. Anecdotal Evidence - Pediatric Atopic DermatitisCompletedNCT03559075
- Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4CompletedNCT03556592Phase 1
- Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic DermatitisWithdrawnNCT03553615Phase 2
- A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic DermatitisCompletedNCT03542994Phase 1
- Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic DermatitisCompletedNCT03540043Phase 2
- Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic DermatitisCompletedNCT03514511Phase 1
- Scratch and Sleep Quantification in Atopic DermatitisCompletedNCT03490877
- Revitalization of Damaged Skin Due to Chronic Skin DiseasesStatus unknownNCT03485560Early Phase 1
- Serotonin Levels in Atopic Dermatitis PatientsStatus unknownNCT03471819
- A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic DermatitisWithdrawnNCT03464526Phase 2
- Efficacy of Topical Coal Tar in Children With Atopic DermatitisStatus unknownNCT03461302Phase 4
- Long-term Observational Study to Evalution the Safety and Efficacy of FURESTEM-AD Inj.Status unknownNCT03458624
- A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic DermatitisCompletedNCT03431610Phase 1
- Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)Active, not recruitingNCT03428646
- Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic DermatitisCompletedNCT03422822Phase 3
- Open-Label Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisStatus unknownNCT03415282Phase 1
- Dupilumab Phase 4 StudyTerminatedNCT03411837
- Atopic Dermatitis: Early Gene Expression Changes as Predictors of Therapeutic Response to Narrow-band UVB TreatmentStatus unknownNCT03402412Not applicable
- Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic DermatitisCompletedNCT03397979Not applicable
- Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic DermatitisCompletedNCT03394677Phase 2
- Effect of Sublingual Immunotherapy in Patients With Atopic DermatitisCompletedNCT03388866Phase 4
- Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque PsoriasisCompletedNCT03381625Phase 2
- EARLYEMOLLIENT - Feasibility of Early Emollient Use in Children With Atopic EczemaCompletedNCT03376243Not applicable
- Establishing the Collaborative Care Model of Traditional Chinese Medicine and Western Medicine-Pediatric Atopic DermatitisStatus unknownNCT03375970Not applicable
- Efficacy and Safety of PR022 Topical Gel to Treat Mild-to-Moderate Atopic DermatitisStatus unknownNCT03351777Phase 2
- Effect of Methotrexate on Inflammatory Response in Adult Atopic Dermatitis PatientsCompletedNCT03327116Not applicable
- Study to Assess the Effect of "Eucerin AtopiControl" on Dermal Symptoms in Patients With Atopic DermatitisCompletedNCT03315611Not applicable
- A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic DermatitisCompletedNCT03304470Phase 2
- Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic DermatitisCompletedNCT03297502Phase 3
- Softened Water for Eczema Prevention Pilot TrialStatus unknownNCT03270566Not applicable
- Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderate to Severe Chronic Atopic Dermatitis(AD)CompletedNCT03269773Phase 3
- Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.CompletedNCT03268174Not applicable
- A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic DermatitisCompletedNCT03257644Phase 1
- Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot StudyTerminatedNCT03257215Phase 4
- In-Use Test With a Cosmetic ProductCompletedNCT03252730Not applicable
- Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisCompletedNCT03252340
- Eucrisa for Atopic DermatitisCompletedNCT03250663Phase 1
- Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic DermatitisTerminatedNCT03245385Phase 2
- Efficacy Of Antenatal Maternal Supplementation With GOS/Inulin Prebiotics On Atopic Dermatitis Prevalence In High-Risk One-Year-Old ChildrenStatus unknownNCT03183440Not applicable
- A Study in Subjects With Moderate Atopic DermatitisCompletedNCT03175354Phase 2
- Atopic Dermatitis (AD) and Food AllergyCompletedNCT03168113
- Efficacy of Fermented Rice Flour for the Treatment of Atopic DermatitisCompletedNCT03157284Not applicable
- A Longitudinal Investigation of Skin Barrier Development From Birth and the Validation of Early Predictors of Atopic Eczema Risk: the Skin Testing for Atopic Eczema Risk (STAR) StudyStatus unknownNCT03143504
- Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age?CompletedNCT03142139
- A Study To Evaluate ASN002 In Subjects With Atopic DermatitisCompletedNCT03139981Phase 1
- Sebum Collection and Skin Barrier Function AnalysisCompletedNCT03112876
- A Phase 1 Study of KHK4083 in Subjects With Atopic DermatitisCompletedNCT03096223Phase 1
- Pharmacodynamics of Omiganan BID in Patients With Atopic DermatitisCompletedNCT03091426Phase 2